All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 111 of 206 pages ‹ First < 109 110 111 112 113 > Last ›
HSL5195
Collier J.
The price of independence.
BMJ 2006 Jun 17;332:(7555):1447-9
http://bmj.bmjjournals.com/cgi/content/short/332/7555/1447?etoc
HSL5197
Saperia J, Ashby D, Gunnell D.
Suicidal behaviour and SSRIs: updated meta-analysis.
BMJ 2006 Jun 17;332:(7555):1453
http://bmj.bmjjournals.com/cgi/content/short/332/7555/1453-a?etoc
HSL7711
Thomas RE, Croal BL, Ramsay C, Eccles M, Grimshaw J.
Effect of enhanced feedback and brief educational reminder messages on laboratory test requesting in primary care: a cluster randomised trial.
Lancet 2006 Jun 17;367:(9527):1990-6
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(06)68888-0
HSL5176
Vedantam S.
Suicide-Risk Tests for Teens Debated
Washington Post 2006 Jun 16
http://www.washingtonpost.com/wp-dyn/content/article/2006/06/15/AR2006061501984.html
HSL5181
Gerstel J.
Road rager, mad spouse: Ill or nasty? : Psychiatric labels cast wide net on human foibles
Toronto Star 2006 Jun 16
http://www.thestar.com/NASApp/cs/ContentServer?pagename=thestar/Layout/Article_Type1&c=Article&cid=1150408210156
HSL5980
Guterman L.
Artificial-blood study has critics seeing red.
Chron High Educ 2006 Jun 16;52:(41):A17
HSL20106
Jenkins R
Doctors unmoved by online drug ads
Australian Doctor 2006 Jun 165
http://www.australiandoctor.com.au/news/latest-news/doctors-unmoved-by-online-drug-ads
HSL6394
Young D.
Regulators demand leaner, succinct drug labeling.
Am J Health Syst Pharm 2006 Jun 15;63:(12):1111-2
http://www.ajhp.org/cgi/content/full/63/12/1111
HSL13641
Mann H.
Hidden Data at the FDA
Bioethics Forum 2006 Jun 15
http://www.bioethicsforum.org/20060615hmann.asp
HSL5186
Carey B.
Study Sees No Gain in Using Antidepressant to Treat Anorexia
New York Times 2006 Jun 14
http://www.nytimes.com/2006/06/14/health/14prozac.html?_r=1&oref=slogin
HSL5658
Jarhult B.
[Pre-launching of drugs--the RLS example].
Lakartidningen 2006 Jun 14-27;103:(24-25):1985
HSL5659
Lafolie P.
[Final reply: drug companies must be allowed to make profit].
Lakartidningen 2006 Jun 14-27;103:(24-25):1979
HSL5981
Weiss R.
'Serious misconduct' by NIH expert found: scientist did not report sending tissues to drug firm and getting paid, report says.
Washington Post 2006 Jun 14;A6
HSL5163
Charities positive about Prozac use
PMLive.com (Pharmaceutical Marketing Ltd) 2006 Jun 13
http://www.pmlive.com/pharm_market/news.cfm?showArticle=1&ArticleID=4671
HSL5182
Leinwand D.
Prescription drugs find place in teen culture
USA Today 2006 Jun 13
http://www.usatoday.com/news/health/2006-06-12-teens-pharm-drugs_x.htm
HSL5112
Boseley S.
Tough curbs on Prozac prescribed for children
The Guardian ( UK) 2006 Jun 12
http://society.guardian.co.uk/print/0,,329502379-106049,00.html
HSL5117
Arndt M.
Big Pharma's Nurse Will See You Now : Drug companies are hiring RNs to educate patients -- and boost marketing
Business Week Online 2006 Jun 12
http://www.businessweek.com/print/magazine/content/06_24/b3988092.htm?chan=mz
HSL5550
Mantone J.
Making research pay. Reaping rewards, conflicts for developing drugs.
Mod Healthc 2006 Jun 12;36:(24):17-8
HSL5113
Henderson D.
The big sleep : Pfizer pushes into the multibillion-dollarmarket to treat insomnia as Americans' demand for help steadily increases
Boston Globe 2006 Jun 11
http://www.boston.com/business/healthcare/articles/2006/06/11/the_big_sleep/
HSL5115
Walkom T.
Big Pharma versus Ontario government no contest : Major climbdown on drug reform bill
Toronto Star 2006 Jun 10
http://www.thestar.com/NASApp/cs/ContentServer?pagename=thestar/Layout/Article_Type1&c=Article&cid=1149889809525&call_pageid=970599119419
HSL5198
Watson R.
EU offers incentives to firms to produce medicines for children.
BMJ 2006 Jun 10;332:(7554):1352
http://bmj.bmjjournals.com/cgi/content/full/332/7554/1352-c
HSL5201
Richards T.
The great medicines scandal.
BMJ 2006 Jun 10;332:(7554):1345-6
http://bmj.bmjjournals.com/cgi/content/full/332/7554/1345
HSL5231
Spurgeon D.
FDA regulations make it harder to sue drug companies
BMJ 2006 Jun 10;332:(7554):1350
http://bmj.bmjjournals.com/cgi/content/short/332/7554/1350-b?etoc
HSL5232
Tanne J.
Congresswoman criticises US drug plan for elderly people
BMJ 2006 Jun 10;332:(7554):1352
http://bmj.bmjjournals.com/cgi/content/short/332/7554/1352?etoc
HSL5233
Siegel-Itzkovich J.
Patients demanding access to cancer drugs call off hunger strike.
BMJ 2006 Jun 10;332:(7554):1352
http://bmj.bmjjournals.com/cgi/content/short/332/7554/1352-a?etoc
HSL5234
Millson DS.
Ethnic differences in risks of adverse reactions: is personalised drug treatment better with pharmacokinetic modelling?
BMJ 2006 Jun 10;332:(7554):1393
http://bmj.bmjjournals.com/cgi/content/short/332/7554/1393?etoc
HSL5235
Mhlongo SW, Mbokazi AJ.
Ethnic differences in risks of adverse reactions: Biomedical approach is insufficient to explain ethnic differences.
BMJ 2006 Jun 10;332:(7554):1393
http://bmj.bmjjournals.com/cgi/content/short/332/7554/1393-a?etoc
HSL5236
Couper MR, Pal SN, Rago L, Sawyer J.
WHO perspective on preventing avoidable harm from medicines.
BMJ 2006 Jun 10;332:(7554):1393-4
http://bmj.bmjjournals.com/cgi/content/short/332/7554/1393-b?etoc
HSL5482
Gardner F.
Tylenol Toxicity Terror
Counterpunch 2006 Jun 10
http://www.counterpunch.org/gardner06102006.html
HSL5116
Kaufman M.
Unapproved Drugs Called 'Threat' : FDA Chief Says Some Medications Bypass Process to Ensure Safety
Washington Post 2006 Jun 9
http://www.washingtonpost.com/wp-dyn/content/article/2006/06/08/AR2006060801542.html
HSL5230
Carter H.
GP role in money-back campaign raises questions
Australian Doctor 2006 Jun 9;1-2
HSL4960
Angell M.
Your Dangerous Drugstore
NY Review of Books 2006 Jun 8
http://www.nybooks.com/articles/19055
HSL5104
When Drug Firms Pay Off Competitors
New York Times 2006 Jun 8
http://www.nytimes.com/2006/06/08/opinion/08thu3.html?th=&emc=th&pagewanted=print
HSL5109
Harris G.
Halt Is Urged for Trials of Antibiotic in Children
New York Times 2006 Jun 8
http://www.nytimes.com/2006/06/08/science/08drug.html?ei=5094&en=6935b6656754232e&hp=&ex=1149825600&partner=homepage&pagewanted=print
HSL5118
Caruso D.
Lawsuits filed over Lipitor side effects
Associated Press 2006 Jun 8
http://news.yahoo.com/s/ap/20060609/ap_on_he_me/lipitor_lawsuits
HSL5199
Itzchaki S, Lazar E, Deland E.
The standardization of expiration-date labels.
N Engl J Med 2006 Jun 8;354:(23):2515-6
HSL5200
Avorn J, Shrank W.
Highlights and a hidden hazard--the FDA's new labeling regulations.
N Engl J Med 2006 Jun 8;354:(23):2409-11
http://content.nejm.org/cgi/content/extract/354/23/2409
HSL5448
Dobson R.
Diethylstilbestrol increases risk of breast cancer death
BMJ 2006 Jun 8;333:(7558):64
http://bmj.bmjjournals.com/cgi/content/short/333/7558/64-d?etoc
HSL5657
Strandberg K.
[Sweden can contribute to safer drug assessment]
Lakartidningen 2006 Jun 8-13;103:(23):1853-5
HSL5105
Experts Fault New FDA Drug Label Changes
Forbes.com ( from HealthDay News) 2006 Jun 7
http://www.forbes.com/forbeslife/health/feeds/hscout/2006/06/07/hscout533155.html
HSL5106
Jewell M.
Guidant letter about risks never sent
Associated Press 2006 Jun 7
http://www.washingtonpost.com/wp-dyn/content/article/2006/06/08/AR2006060800295.html
HSL5114
Agovino T.
Spending on specialty drugs soar
Associated Press 2006 Jun 7
http://www.kansascity.com/mld/kansascity/living/health/14757214.htm
HSL5030
Carey B.
Use of Antipsychotics by the Young Rose Fivefold
New York Times 2006 Jun 6
http://www.nytimes.com/2006/06/06/health/06psych.html?th=&emc=th&pagewanted=print
HSL5107
10-year-olds given antidepressants
Sydney Morning Herald ( from AAP ) 2006 Jun 6
http://www.smh.com.au/news/childrens-health/10yearolds-given-antidepressants/2006/06/06/1149359715882.html
HSL5108
Briley J.
Performance-Enhancing Placebos
Washington Post 2006 Jun 6
http://www.washingtonpost.com/wp-dyn/content/article/2006/06/05/AR2006060500857.html?referrer=emailarticle
HSL5110
Moncreff J, Cohen D.
Do Antidepressants Cure or Create Abnormal Brain States?
PLoS Medicine ( Public Library of Science) 2006 Jun 6
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10%2E1371%2Fjournal%2Epmed%2E0030240
HSL5258
Consumers, Corporate Social Responsibility and Drug Promotion : Branding the Cure
Consumers International 2006 Jun 6
http://www.consumersinternational.org/Templates/Internal.asp?NodeID=95352&int1stParentNodeID=89650&int2ndParentNodeID=95352
HSL5033
Neurath P.
Ban on drug samples urged
Puget Sound Business Journal ( Seattle) 2006 Jun 5
http://seattle.bizjournals.com/seattle/stories/2006/06/05/story4.html?t=printable
HSL5111
Anger syndrome 'under-diagnosed'
BBC News 2006 Jun 5
http://news.bbc.co.uk/1/hi/health/5049610.stm
HSL5120
NZ R&D 'on the edge of the abyss'
Pharma in Focus ( Australia) 2006 Jun 5
http://www.pharmainfocus.com.au/news.asp?newsid=1177
HSL8256
Simons J.
Merck's $4 billion PR problem
CNNMoney.com 2006 Jun 5
http://money.cnn.com/2006/06/02/news/companies/pluggedin_fortune/index.htm
HSL5031
Lazaroff L.
Pfizer looks for wonder drug to cure sales ills
Chicago Tribune 2006 Jun 4
http://www.chicagotribune.com/business/chi-0606040177jun04,1,521689.story?coll=chi-business-hed
HSL7161
Herper M.
Behind Pfizer's Failure
Forbes.com 2006 Jun 4
http://www.forbes.com/2006/12/03/pfizer-heartdisease-drug-biz-cx_mh_1204torcetrapib.html?partner=yahootix
HSL5032
Ainsworth C.
Mother's diet can tinker with baby's genes
Nature 2006 Jun 2
http://www.nature.com/news/2006/060529/full/060529-10.html#top
HSL20023
Waters M
Lunch rights
Australian Doctor 2006 Jun 223
HSL5007
Emslie GJ, Wagner KD, Kutcher S, Krulewicz S, Fong R, Carpenter DJ, Lipschitz A, Machin A, Wilkinson C.
Paroxetine Treatment in Children and Adolescents With Major Depressive Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial.
J Am Acad Child Adolesc Psychiatry 2006 Jun 01;45:(6):709-719
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?doi=10.1097/01.chi.0000214189.73240.63
HSL5009
Krasner J.
Senate OK's licensing of drug reps
boston.com business 2006 Jun 1
http://www.boston.com/business/globe/articles/2006/06/01/senate_oks_licensing_of_drug_reps/
HSL5052
Klok RM, Boersma C, Oosterhuis I, Visser ST, DE Jong-VAN DEN Berg LT, Postma MJ.
Switch patterns before and after patent expiry of omeprazole: a case study in The Netherlands.
Aliment Pharmacol Ther 2006 Jun 1;23:(11):1595-600
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2036.2006.02921.x
HSL5084
Fugh-berman A, Batt S.
'This may sting a bit': cutting CME’s ties to pharma
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8:(6):412-415
http://www.ama-assn.org/ama1/pub/upload/mm/384/oped1_16260.pdf
HSL5119
Mack J.
Pharma Tail Wags Patient Dogs
Pharma Marketing News ( Blog) 2006 Jun 1
http://pharmamkting.blogspot.com/2006/06/pharma-tail-wags-patient-dogs.html
HSL5274
Reenan J.
Rx for physician prescribing practices
Virtual Mentor. 2006; 8: 2006 Jun 1;8:(6):359-361
http://www.ama-assn.org/ama/pub/category/16249.html
HSL5275
Finkelstein JA.
Unnecessary antibiotics
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8:(6):362-366
http://www.ama-assn.org/ama/pub/category/16250.html
HSL5276
Adair R.
Hidden costs of free samples
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8:(6):367-371
http://www.ama-assn.org/ama/pub/category/16251.html
HSL5277
Sierles FS.
The gift-giving influence
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8:(6):372-376
http://www.ama-assn.org/ama/pub/category/16252.html
HSL5278
Fine PG.
Prescribing placebos
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8:(6):377-380
http://www.ama-assn.org/ama/pub/category/16253.html
HSL5279
Ruiz JG, Hagenlocker B.
E-prescribing
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8:(6):381-386
http://www.ama-assn.org/ama/pub/category/16254.html
HSL5280
Perry P.
Patent (and public health) pending
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8:(6):387-391
http://www.ama-assn.org/ama/pub/category/16255.html
HSL5281
Krautkramer CJ.
Neurontin and off-label marketing
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8:(6):397-402
HSL5282
Carpenter D
Reputation, gatekeeping and the politics of post-marketing drug regulation
Virtual Mentor: Ethics Journal of the American Medical Association 2206 Jun 1;8:(6):403-406
http://www.ama-assn.org/ama/pub/category/16258.html
HSL5283
Kravitz RL, Halpern J.
Direct-to-consumer drug ads, patient autonomy and the responsible exercise of power
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8:(6):407-411
http://www.ama-assn.org/ama/pub/category/16259.html
HSL5284
Kopelow M.
Independence in continuing medical education
Virtual Mentor: Ethics Journal of the American Medical Association 2006 Jun 1;8:(6):416-419
http://www.ama-assn.org/ama/pub/category/16261.html
HSL5390
Mabasa VH, Ma J.
Effect of a Therapeutic Maximum Allowable Cost (MAC) Program on the Cost and Utilization of Proton Pump Inhibitors in an Employer-Sponsored Drug Plan in Canada.
J Manag Care Pharm 2006 Jun 01;12:(5):371-6
HSL5401
Windish DM, Diener-West M.
A clinician-educator's roadmap to choosing and interpreting statistical tests.
J Gen Intern Med 2006 Jun 01;21:(6):656-60
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2006.00390.x
HSL5402
Jacobs EA, Rolle I, Ferrans CE, Whitaker EE, Warnecke RB.
Understanding African Americans' views of the trustworthiness of physicians.
J Gen Intern Med 2006 Jun 01;21:(6):642-7
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2006.00485.x
HSL5415
Vieira FS, Zucchi P.
[Price differences between generic and innovator medicines in Brazil].
Rev Saude Publica 2006 Jun 01;40:(3):444-9
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102006000300012&tlng=en&lng=en&nrm=iso
HSL5419
Dieppe P.
Complicity theory: an explanation for the 'coxib problem'?
J R Soc Med 2006 Jun 01;99:(6):273-4
http://www.jrsm.org/cgi/content/full/99/6/273
HSL5420
Weatherall M, Aldington S, Caldwell B, Beasley R.
Inconsistencies in cardiovascular data from COX-2 inhibitor trials--is it a class effect?
J R Soc Med 2006 Jun 01;99:(6):275-6
http://www.jrsm.org/cgi/content/full/99/6/275
HSL5433
Johnson DH.
Keynote comment: Cancer drug pricing in the USA.
Lancet Oncol 2006 Jun 01;7:(6):444-5
http://linkinghub.elsevier.com/retrieve/pii/S1470-2045(06)70702-1
HSL5434
Karch AM.
The gray areas of black box warnings.
Am J Nurs 2006 Jun 01;106:(6):77-8
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000446-200606000-00037
HSL5594
Lanier WL.
Editor's note: Industry support of articles published in Mayo Clinic Proceedings.
Mayo Clin Proc 2006 Jun 01;81:(6):851-2
HSL5661
Frantz S.
Industry sweats after patent verdict.
Nat Rev Drug Discov 2006 Jun 01;5:(6):443-4
HSL5666
Ruel MD.
Using race in clinical research to develop tailored medications. Is the FDA encouraging discrimination or eliminating traditional disparities in health care for African Americans?
J Leg Med 2006 Jun 01;27:(2):225-41
http://taylorandfrancis.metapress.com/(nhajxw55xm42kfmxadioudb5)/app/home/contribution.asp?referrer=parent&backto=issue,4,6;journal,1,26;linkingpublicationresults,1:102467,1
HSL5765
Montgomery JH.
Industry funding and author-industry affiliation in clinical trials in psychiatry.
Am J Psychiatry 2006 Jun 01;163:(6):1110-1
http://ajp.psychiatryonline.org/cgi/content/full/163/6/1110
HSL5818
Livesey JE, Chiew YF.
Antimicrobial drug utilisation in Dunedin Hospital, New Zealand, and its association with antimicrobial resistance.
Pathology 2006 Jun 01;38:(3):245-8
http://taylorandfrancis.metapress.com/(sp3lak55wbj4tc55al43cs55)/app/home/contribution.asp?referrer=parent&backto=issue,10,26;journal,1,59;linkingpublicationresults,1:102228,1
HSL5821
Hassan F.
Leading change from the top line. Interview by Thomas A Stewart and David Champion
Harv Bus Rev. 2006 Jul-Aug 01;84:(7-8):188
HSL5823
While A.
Full prescribing rights are now a reality.
Br J Community Nurs 2006 Jun 01;11:(6):270
HSL5824
Fleck F.
No delayed disclosure for registration of clinical trials.
Bull World Health Organ 2006 Jun 01;84:(6):430
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000600006&lng=en&nrm=iso&tlng=en
HSL5826
Mahon SM.
Impact of direct-to-consumer advertising on healthcare providers and consumers.
Clin J Oncol Nurs 2006 Jun 01;10:(3):417-20
HSL5827
Wilson S.
In defense of full disclosure.
JAAPA 2006 Jun 01;19:(6):48-9
HSL5829
Smith R.
Conflicts of interest: how money clouds objectivity.
J R Soc Med 2006 Jun 01;99:(6):292-7
http://www.jrsm.org/cgi/content/full/99/6/292http://
HSL5831
Pauls MA, Ackroyd-Stolarz S.
Identifying bioethics learning needs: a survey of Canadian emergency medicine residents.
Acad Emerg Med 2006 Jun 01;13:(6):645-52
http://www.aemj.org/cgi/content/full/13/6/645
HSL5928
Smith M.
Physicians and the pharmaceutical industry--'dualities of interest'.
Intern Med J 2006 Jun 01;36:(6):401
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2006.01091.x
HSL5988
Wallace LS, Roskos SE, Weiss BD.
Readability characteristics of consumer medication information for asthma inhalation devices.
J Asthma 2006 Jun-Jul 01;43:(5):375-8
http://taylorandfrancis.metapress.com/(4e21iavbbi4fxefxrcsnxd45)/app/home/contribution.asp?referrer=parent&backto=issue,8,13;journal,2,48;linkingpublicationresults,1:107839,1
HSL5990
Platow MJ, van Knippenberg D, Haslam SA, van Knippenberg B, Spears R.
A special gift we bestow on you for being representative of us: Considering leader charisma from a self-categorization perspective.
Br J Soc Psychol 2006 Jun 01;45:(Pt):
http://www.ingentaconnect.com/content/bpsoc/bjsp/2006/00000045/00000002/art00005?token=005c1ddd4cbb9106b86ab726e2d2954496f642f466f256720297d7625737b517b6c24385176384bc08e0d90edf5f
HSL5991
Shirkey HC.
Therapeutic orphans--everybody's business.
Ann Pharmacother 2006 Jun 01;40:(6):1174
http://www.theannals.com/cgi/reprint/40/6/1174
HSL6043
Westerlund LT, Bjork HT.
Pharmaceutical care in community pharmacies: practice and research in Sweden.
Ann Pharmacother 2006 Jun 01;40:(6):1162-9
http://www.theannals.com/cgi/content/full/40/6/1162
HSL6045
Haefeli WE.
[Drug administration errors--what information is required to enable patients to safely take their drugs?]
Ther Umsch 2006 Jun 01;63:(6):363-5
HSL6046
Blockman M.
Selective serotonin reuptake inhibitors in children with major depression.
S Afr Med J 2006 Jun 01;96:(6):476-7
http://blues.sabinet.co.za/WebZ/Authorize?sessionid=0:autho=pubmed:password=pubmed2004&/AdvancedQuery?&format=F&next=images/ejour/m_samj/m_samj_v96_n6_a3.pdf
HSL6054
Rapoport AM.
More on conflict of interest from a clinical professor of neurology in private practice at a headache center.
Headache 2006 Jun 01;46:(6):1020-1
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1526-4610.2006.00474_2.x
HSL6055
Purdy RA.
Minding our 'Ps' and 'Qs'!
Headache 2006 Jun 01;46:(6):1019-20
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1526-4610.2006.00474_1.x
Page 111 of 206 pages ‹ First < 109 110 111 112 113 > Last ›
